Cellomics, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Cellomics, Inc. - overview

About

Cellomics, Inc. develops and markets high content screening systems for drug screening and localization within living cells.

Current Investors

Delphi Ventures, InterWest Partners, Oxford Bioscience Partners

Primary Industry

Healthcare

Sub Industries

Epidemiology

Website

www.cellomics.com

Verticals

HealthTech

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.